IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Healthcare
Sub Sector: specialize in a diverse range of products across several segments, including Dietary/Nutritional Supplements, Cosmetics, Ayurvedic / Herbal, Veterinary Feed Supplements, and Homecare segment.
Exchange:
NSE
Emerge
Influx Healthtech Limited is a Mumbai-based healthcare product-focused company that has carved a niche in contract manufacturing the Company carter as third-party manufacturer. The company operates three manufacturing facilities located in Thane, Maharashtra, covering an area approximately 6,500 square feet, 13,000 square feet, and 14,000 square feet. These manufacturing plants are certified with GMP (Good Manufacturing Practice), HACCP (Hazards Analysis & Critical Control Points), ISO 22000, and Halal, and are equipped with advanced machinery, a quality control department, and a skilled workforce. Their company operates as a Contract Development and Manufacturing Organization (CDMO), which is a third-party manufacturer. They specialize in a diverse range of products across several segments, including Dietary/Nutritional Supplements, Cosmetics, Ayurvedic / Herbal, Veterinary Feed Supplements, and Homecare segment. This includes the production of Active Pharmaceutical Ingredients (APIs) and the manufacturing of finished dosage forms such as tablets, capsules, and injectables. In 2020, Influx was established by Their visionary founder, Mr. Munir Abdul Ganee Chandniwala. His dedication and passion laid the foundation for Their organization, . Mr. Munir Abdul Ganee Chandniwala completed a Post Graduate degree in Management and Business Administration from Atharva School of Business, Mumbai (2004-2006), a Bachelor of Pharmacy from the University of Pune (2002), and a Doctor of Philosophy program from Bharatiya Shiksha Parishad, Uttar Pradesh (2010). He has Approximately 18 years of experience in the nutraceutical, cosmetics, ayurvedic, and homecare industries. He is also registered with the Maharashtra State Pharmacy Council as a registered pharmacist. Additionally, he completed a Diploma in Nutrition from Fab Academe, a division of Fabulous Body Inc., California, United States, in 2019. Since 2005, he has been a successful entrepreneur in the field of third-party manufacturing, contract development, and manufacturing.
Maashitla Securities Private Limited
Influx Healthtech operates in Healthcare and specialize in a diverse range of products across several segments, including Dietary/Nutritional Supplements, Cosmetics, Ayurvedic / Herbal, Veterinary Feed Supplements, and Homecare segment.. The Issue would be listed on SME. The registrar of the Issue is Maashitla Securities Private Limited. The IPO type of Influx Healthtech is Book Building Process and Object of issue is
Merchant Banker of Influx Healthtech IPO is Corporate Capital Ventures Private Limited
The DRHP (Draft Red Herring Prospectus) of Influx Healthtech IPO was filed on 02 Sep 2024.
No, Influx Healthtech IPO is not yet listed. See other upcoming SME IPOs here.
The IPO open date and IPO close date of Influx Healthtech are not available now. You can apply in Influx Healthtech IPO online using either UPI or ASBA as a payment method. ASBA IPO application can be done through net banking of your bank account. UPI IPO application is also offered by brokers, though they don't handle any banking services.
Why Us?
